Evidence map›Paper›PMID 38467730›Full record

ArticleEuropean journal of human genetics : EJHG2024

Evidence for the additivity of rare and common variant burden throughout the spectrum of intellectual disability.

Lea Urpa, Mitja I Kurki, Elisa Rahikkala, Eija Hämäläinen, Veikko Salomaa, Jaana Suvisaari, Riikka Keski-Filppula, Merja Rauhala, Satu Korpi-Heikkilä, Jonna Komulainen-Ebrahim and 10 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Clinical and genetic characterization of intellectual disability.Developmental medicine and child neurology · 2026
    Article
  2. Review
  3. Article
  4. Individuals with intellectual disability have an increased burden ofmedRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. Novel insights into cancer predisposition genes.European journal of human genetics : EJHG · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Lea UrpaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. lea.urpa@helsinki.fi.ORCID 0000-0002-8712-3518
Mitja I KurkiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Elisa RahikkalaResearch Unit of Clinical Medicine, University of Oulu, Oulu, Finland.ORCID 0000-0003-2760-7059
Eija HämäläinenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Veikko SalomaaFinnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0001-7563-5324
Jaana SuvisaariFinnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0001-7167-0990
Riikka Keski-FilppulaResearch Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
Merja RauhalaOulu University Hospital, Center for Intellectual Disability Care, Oulu, Finland.
Satu Korpi-HeikkiläOulu University Hospital, Center for Intellectual Disability Care, Oulu, Finland.
Jonna Komulainen-EbrahimResearch Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
Heli HelanderResearch Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
Päivi VieiraResearch Unit of Clinical Medicine, University of Oulu, Oulu, Finland.ORCID 0000-0002-0796-8706
Johanna UusimaaResearch Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
Jukka S MoilanenResearch Unit of Clinical Medicine, University of Oulu, Oulu, Finland.ORCID 0000-0002-8041-3205
Jarmo KörkköOulu University Hospital, Center for Intellectual Disability Care, Oulu, Finland.
Tarjinder SinghDepartment of Psychiatry, Columbia University, New York, NY, 10032, USA.ORCID 0000-0003-0601-6815
Outi KuisminInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Olli PietiläinenThe Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-4387-1861
Aarno PalotieInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0002-2527-5874
Mark J DalyInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Oulu University Hospital · FIBroad Institute · USFinnish Institute for Health and Welfare · FIUniversity of Helsinki · FIInstitute for Molecular Medicine Finland · FIMIND Research Institute · US

Funding

Large Scale Sequencing and Analysis of GenomesU54HG003067 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY, LANDER, ERIC S · 2004 to 2015
$568.6M
Center for Common Disease GeneticsUM1HG008895 · NHGRI · BROAD INSTITUTE, INC. · PI DALY, MARK JOSEPH, GABRIEL, STACEY · 2016 to 2020
$111.2M
3/3-Identifying regulatory mutations that influence neuropsychiatric diseaseU01MH105669 · NIMH · BROAD INSTITUTE, INC. · PI DALY, MARK JOSEPH · 2014 to 2018
$4.5M
NHGRI NIH HHS U54 HG003067NHGRI NIH HHS UM1 HG008895NIMH NIH HHS U01 MH105669Wellcome Trust
6 · The paper itself

Abstract

Intellectual disability (ID) is a common disorder, yet there is a wide spectrum of impairment from mild to profoundly affected individuals. Mild ID is seen as the low extreme of the general distribution of intelligence, while severe ID is often seen as a monogenic disorder caused by rare, pathogenic, highly penetrant variants. To investigate the genetic factors influencing mild and severe ID, we evaluated rare and common variation in the Northern Finland Intellectual Disability cohort (n = 1096 ID patients), a cohort with a high percentage of mild ID (n = 550) and from a population bottleneck enriched in rare, damaging variation. Despite this enrichment, we found only a small percentage of ID was due to recessive Finnish-enriched variants (0.5%). A larger proportion was linked to dominant variation, with a significant burden of rare, damaging variation in both mild and severe ID. This rare variant burden was enriched in more severe ID (p = 2.4e-4), patients without a relative with ID (p = 4.76e-4), and in those with features associated with monogenic disorders. We also found a significant burden of common variants associated with decreased cognitive function, with no difference between mild and more severe ID. When we included common and rare variants in a joint model, the rare and common variants had additive effects in both mild and severe ID. A multimodel inference approach also found that common and rare variants together best explained ID status (ΔAIC = 16.8, ΔBIC = 10.2). Overall, we report evidence for the additivity of rare and common variant burden throughout the spectrum of intellectual disability.

Indexed as

Intellectual DisabilityAdultFemaleFinlandGenetic VariationHumansMale

Identifiers

PMID38467730
PMCPMC11061114
OpenAlexW4392652121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.